Evidence map›Paper›PMID 39519039›Full record

ArticleInternational journal of molecular sciences2024

Rolling-Translated circRUNX2.2 Promotes Lymphoma Cell Proliferation and Cycle Transition in Marek's Disease Model.

Lulu Wang, Gang Zheng, Yuqin Yang, Junfeng Wu, Yushuang Du, Jiahua Chen, Changjun Liu, Yongzhen Liu, Bo Zhang, Hao Zhang and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Roles and Applications of Circular RNA in Virus Infection.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lulu WangFrontiers Science Center for Molecular Design Breeding (MOE), China Agricultural University, Beijing 100193, China.ORCID 0000-0001-9899-4493
Gang ZhengFrontiers Science Center for Molecular Design Breeding (MOE), China Agricultural University, Beijing 100193, China.
Yuqin YangFrontiers Science Center for Molecular Design Breeding (MOE), China Agricultural University, Beijing 100193, China.
Junfeng WuFrontiers Science Center for Molecular Design Breeding (MOE), China Agricultural University, Beijing 100193, China.
Yushuang DuFrontiers Science Center for Molecular Design Breeding (MOE), China Agricultural University, Beijing 100193, China.
Jiahua ChenFrontiers Science Center for Molecular Design Breeding (MOE), China Agricultural University, Beijing 100193, China.
Changjun LiuDivision of Avian Infectious Diseases, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin 150001, China.
Yongzhen LiuDivision of Avian Infectious Diseases, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin 150001, China.
Bo ZhangFrontiers Science Center for Molecular Design Breeding (MOE), China Agricultural University, Beijing 100193, China.
Hao ZhangFrontiers Science Center for Molecular Design Breeding (MOE), China Agricultural University, Beijing 100193, China.ORCID 0000-0003-4093-5647
Xuemei DengFrontiers Science Center for Molecular Design Breeding (MOE), China Agricultural University, Beijing 100193, China.
Ling LianFrontiers Science Center for Molecular Design Breeding (MOE), China Agricultural University, Beijing 100193, China.

Funding

Agriculture Research Systems CARS-40Chinese Universities Scientific Fund 2023TC198Farm Animals Germplasm Resource Platform 0National Key Research and Development Program of China 2022YFF1000200National Natural Science Foundation of China 32161143037National Natural Science Foundation of China 32272865Programs for Chang jiang Scholars and Innovative Research Team in University IRT_15R62
6 · The paper itself

Abstract

Marek's disease (MD), an immunosuppressive disease induced by the Marek's disease virus (MDV), is regarded as an ideal model for lymphoma research to elucidate oncogenic and anti-oncogene genes. Using this model, we found that circRUNX2.2, derived from exon 6 of RUNX2, was significantly upregulated in MDV-infected tumorous spleens. In this study, we deeply analyzed the potential role of circRUNX2.2 in lymphoma cells. An open reading frame (ORF) in circRUNX2.2 with no stop codon was predicted, and small peptides (named circRUNX2.2-rt) presenting multiple ladder-like bands with different molecular weights encoded by circRUNX2.2 were detected via Western blotting assay. The polysome fraction assay reconfirmed the translation ability of circRUNX2.2, which could be detected in polysome fractions. Subsequent analysis verified that it translated in a rolling circle manner, rather than being assisted by the internal ribosome entry site (IRES) or m6A-mediated mechanism. Furthermore, we found that circRUNX2.2-rt was potently induced in MSB1 cells treated with sodium butyrate (NaB), which reactivated MDV and forced the MDV transition from the latent to reactivation phase. During this phase, MDV particles were clearly observed by electron microscopy, and the viral gene pp38 was also significantly upregulated. A biological function study showed that circRUNX2.2-rt promoted cell proliferation and cell cycle transition from the S to G2 phase and inhibited the apoptosis of MSB1. Further immunoprecipitation and mass spectrometry assays showed that 168 proteins potentially interacting with circRUNX2.2-rt were involved in multiple pathways related to cell cycle regulation, which proved that circRUNX2.2-rt could bind or recruit proteins to mediate the cell cycle.

Indexed as

Cell ProliferationChickensLymphomaMarek DiseaseAnimalsCell CycleCell Line, TumorHerpesvirus 2, GallidchickenCircRUNX2.2-rtlymphomaMarek’s diseaserolling circle manner

Identifiers

PMID39519039
PMCPMC11545863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.